StonvexLoading…
StonvexStonvexStonvexCore line items from KR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $147.64B | $147.12B | $150.04B | $148.26B |
Operating Income | $1.89B | $3.85B | $3.10B | $4.13B |
Net Income | $1.02B | $2.67B | $2.16B | $2.24B |
EPS (Diluted) | $1.54 | $3.67 | $2.96 | $3.06 |
Total Assets | $49.95B | $52.62B | $50.51B | $49.62B |
Total Liabilities | $44.02B | $44.34B | $38.90B | $39.61B |
Cash & Equivalents | $3.33B | $3.96B | $1.88B | $1.01B |
Free Cash Flow OCF − CapEx | $3.46B | $1.78B | $2.88B | $1.42B |
Shares Outstanding | 655.00M | 720.00M | 725.00M | 727.00M |